Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Tennessee for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Tennessee only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Tennessee (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

David Fingerhut (NPI 1326363086)

Field	Value
Entity Type	Individual
Organization	David Fingerhut
Address	1432 Kimbrough Rd
City	Germantown
State	TN
ZIP	38138
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	April 6, 2010

Payer Source	Total Paid
Medicare	$2.8M
Medicaid	$0

Key Findings

This provider is effectively a single-payer operator: lifetime Medicare revenue is $2.8M and there is no Medicaid billing on file, so the practice’s payer exposure and revenue strategy appear concentrated on Medicare beneficiaries rather than Medicaid enrollees. That payer mix implication is important for network contracting and utilization-management discussions because Medicaid-managed care considerations are not visible in the claims on file.

Revenue is highly concentrated in a very small set of services: the precomputed top 3 Medicare codes account for 89.4% of Medicare revenue, driven by J0178 (66.6%), J2777 (17.8%), and 67028 (5.0%). This concentration means the practice’s financial performance is heavily dependent on intravitreal injection drugs and isolated vitreous injections rather than a broad mix of office-based evaluation-and-management services.

The code mix and descriptions identify an injection- and imaging-focused retina practice: high-volume anti-VEGF and related injections (J0178 aflibercept, J2777 faricimab, J2778 ranibizumab, J9035 bevacizumab) combined with retinal imaging (92134 OCT, 92235 fluorescein angiography, 92242 multiframe angiography) and occasional laser (67228). This pattern is consistent with a retina specialist operation that runs frequent intravitreal injection sessions supported by diagnostic imaging rather than a primarily E&M-driven clinic.

Competitive standing is strong on several procedural lines: J0178 ranks #238 of 3204 nationally (93th percentile) and is described as notably above typical national volume, and 92134 ranks #524 of 26868 (98th percentile) and is flagged as an extreme outlier far above typical national volume. Those rank positions signal national-level strength in both aflibercept injections and retinal OCT imaging relative to peers, while the practice is less dominant on many other codes.

Other procedure volumes are more typical for a retina specialist: J2777 ranks #623 of 2039 (69th percentile) and 67028 ranks #654 of 4255 (85th percentile), both characterized as typical or unremarkable volumes nationally. This suggests pockets of above-average scale (notably J0178 and 92134) complemented by otherwise routine retina procedure activity rather than broad dominance across all retinal services.

Evaluation-and-management revenue is a small share of the Medicare mix, consistent with a procedure-centric model: 99214 produced $35.3K (1.3% of Medicare revenue) across 465 claims and 99213 produced $26.6K (0.9% of Medicare revenue) across 451 claims. Those figures indicate that billed procedures and drug administrations drive revenue more than office E&M visits, which has implications for staffing, scheduling, and reimbursement negotiations.

Operational and contract-risk considerations include reliance on high-cost drugs and injection volume: J0178 shows 2.7K claims, $689 avg paid/claim, and $1.9M revenue, and J2777 shows 17.3K claims, $29 avg paid/claim, and $501.1K revenue. Payers and procurement teams should note the concentration in branded and specialty injectable drugs and the practice’s throughput model when assessing formulary, prior-authorization, and site-of-care policies.

The provider has been an active NPI registrant since 2010-04-06 (~16 years ago), indicating an established practice history that aligns with sustained Medicare billing patterns. That tenure, combined with the observed high volumes for specific retina services, suggests durable referral relationships and an operational focus on high-frequency injection and imaging workflows.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

19 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,720	$690	$1.9M
J2777	Injection, faricimab‑svoa, 0.1 mg	17,280	$30	$501.1K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,640	$90	$140.6K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,740	$30	$74.1K
J2778	Injection, ranibizumab, 0.1 mg	360	$180	$65.5K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	470	$80	$35.3K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	350	$90	$31.5K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	450	$60	$26.6K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	170	$90	$15.9K
J9035	Injection, bevacizumab, 10 mg	250	$60	$14.2K

Showing 1–10 of 19

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 19 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Tennessee Distribution

David Fingerhut — 2 of 19 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Tennessee

Full comparison — all codes billed, vs. state median

19 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	5	80	790	$680	$769.8K
J2777	21	50	15,060	$30	$592.1K
J2778	35	40	1,340	$180	$370.2K
67028	26	80	1,130	$90	$98.5K
66821	213	230	60	$120	$20.8K
92014	173	810	120	$80	$19.2K
J9035	25	70	140	$50	$17.1K
99214	1,446	11,370	120	$80	$16.6K
99215	1,565	2,710	40	$110	$8.3K
92134	16	600	60	$30	$8.2K

Showing 1–10 of 19

Related Providers

Other providers that share a Tax Identification Number (TIN) with David Fingerhut, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Shil Patel	VA	Ophthalmology Physician	$6.1M	$0
Stephen Huddleston	TN	Retina Specialist (Ophthalmology) Physician	$5.7M	$0
James Pate	NC	Ophthalmology Physician	$5.2M	$0
Nitin Gupta	NC	Ophthalmology Physician	$4.7M	$0
Philip Ames	FL	Ophthalmology Physician	$3.5M	$350
Matthew Cole	TN	Ophthalmology Physician	$3.3M	$0
William Clark	SC	Ophthalmology Physician	$3.3M	$0
Adam Pflugrath	SC	Retina Specialist (Ophthalmology) Physician	$3.1M	$0
Scott Sullivan	TN	Retina Specialist (Ophthalmology) Physician	$3M	$0
Vrf Eye Specialty Group, Plc	TN	Ophthalmology Physician	$0	$2.5M

Nearby Providers

Other providers in the same ZIP code as David Fingerhut, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Byram Healthcare Centers, Inc.	TN	Durable Medical Equipment & Medical Supplies	$0	$44.3M
Campbell Clinic, PC	TN	Orthopaedic Surgery Physician	$0	$28M
The West Clinic P.C.	TN	Specialist	$0	$16M
Poplar Avenue Clinic PLLC	TN	Gynecologic Oncology Physician	$0	$9.7M
Diagnostic Ultrasound Consultants	TN	Diagnostic Radiology Physician	$0	$8.5M
Mid-south Imaging & Therapeutics, P.A.	TN	Diagnostic Radiology Physician	$0	$8.2M
David Portnoy	TN	Hematology & Oncology Physician	$6.5M	$0
Stern Cardiovascular Foundation, Inc	TN	Cardiovascular Disease Physician	$0	$4.7M
G I Diagnostic And Therapeutic Center LLC	TN	Endoscopy Clinic/Center	$4.2M	$8.6K
Memphis Neurology PLLC	TN	Neurology Physician	$0	$3.9M

David Fingerhut — Billing Profile & Reimbursement Data

Sign up for David Fingerhut — Billing Profile & Reimbursement Data policy alerts

David Fingerhut — Billing Profile & Reimbursement Data

Sign up for David Fingerhut — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References